Armata Pharmaceuticals (ARMP) Operating Income: 2013-2024
Historic Operating Income for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$42.4 million.
- Armata Pharmaceuticals' Operating Income fell 18.14% to -$2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$17.2 million, marking a year-over-year decrease of 6.34%. This contributed to the annual value of -$42.4 million for FY2024, which is 3.78% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Operating Income of -$42.4 million as of FY2024, which was down 3.78% from -$40.9 million recorded in FY2023.
- In the past 5 years, Armata Pharmaceuticals' Operating Income ranged from a high of -$21.6 million in FY2020 and a low of -$42.4 million during FY2024.
- In the last 3 years, Armata Pharmaceuticals' Operating Income had a median value of -$40.9 million in 2023 and averaged -$40.1 million.
- Data for Armata Pharmaceuticals' Operating Income shows a maximum YoY plummeted of 55.09% (in 2022) over the last 5 years.
- Armata Pharmaceuticals' Operating Income (Yearly) stood at -$21.6 million in 2020, then fell by 10.35% to -$23.8 million in 2021, then plummeted by 55.09% to -$36.9 million in 2022, then dropped by 10.68% to -$40.9 million in 2023, then dropped by 3.78% to -$42.4 million in 2024.